Evofem Biosciences, Inc. (EVFM): debt financing — Evofem receives default notice; Baker Bros. accelerates $92.8M repayment demand

Evofem Biosciences, Inc.

Baker Bros. Advisors claims Evofem failed to maintain Required Reserve Amount under SPA; demands $92.8M within three business days.
Evofem disagrees with default claim, invited Designated Agent to rescind notice; exploring all options.
Default based on Section 9.1(e) of Securities Purchase Agreement dated April 2020; acceleration equal to 2x outstanding plus interest.
Inadvertent internal disclosure triggered Item 7.01 FD filing; company does not admit materiality.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Evofem Biosciences, Inc. faced acceleration on debt of approximately $92.8 million representing two times the sum of the outstanding balance and all accrued and unpaid interes with Baker Bros. Advisors, LP maturing within three business days of receipt of the Notice of Default.

Principal: approximately $92.8 million representing two times the sum of the outstanding balance and all accrued and unpaid interes
Counterparty: Baker Bros. Advisors, LP
Maturity: within three business days of receipt of the Notice of Default
Event: acceleration

Exact text from the filing

The Designated Agent, at the director of the Purchasers, has accelerated repayment of the outstanding balance payable and elected its remedies pursuant to Section 5.07(b) of the Securities Purchase Agreement. As a result, approximately $92.8 million representing two times the sum of the outstanding balance and all accrued and unpaid interest thereon and all other amounts due under the SPA and other documents is due and payable within three business days of receipt of the Notice of Default.

View on SEC.gov

Browse all debt financings →

Evofem Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001618835-23-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.